Dr. George is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
450 Brookline Ave
Boston, MA 02215Phone+1 617-632-5204Fax+1 617-632-3408- Is this information wrong?
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1998 - 2001- Tufts Medical CenterResidency, Internal Medicine, 1997 - 1998
University of North Carolina HospitalsResidency, Internal Medicine, 1995 - 1997
University of Massachusetts Medical SchoolClass of 1995
Certifications & Licensure
NH State Medical License 2004 - Present
MA State Medical License 1999 - 2026
NC State Medical License 1996 - 1998- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2013-2014
- America's Top Doctors for Cancer Castle Connolly, 2012-2013
Clinical Trials
- Study of Gemcitabine and Vinorelbine in Soft Tissue Sarcomas Start of enrollment: 2003 Feb 01
- Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma Start of enrollment: 2009 Feb 01
- RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant Neoplasms Start of enrollment: 2009 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- A Single Arm Phase 2 Trial of Trametinib in Patients With Locally Advanced or Metastatic Epithelioid Hemangioendothelioma.Schuetze, S., Ballman, K., Heise, R., Ganjoo, K., Davis, E., George, S., Burgess, M., Choy, E., Shepard, D., Tinoco, G., Hirbe, A., Kelly, C., Attia, S., Deshpande, H....> ;Clinical Cancer Research. 2024 Mar 6
- KIT ATP-Binding Pocket/Activation Loop Mutations in GI Stromal Tumor: Emerging Mechanisms of Kinase Inhibitor Escape.Mühlenberg, T., Falkenhorst, J., Schulz, T., Fletcher, B., Teuber, A., Krzeciesa, D., Klooster, I., Lundberg, M., Wilson, L., Lategahn, J., von Mehren, M., Grunewald, ...> ;Journal of Clinical Oncology. 2024 Feb 26
- Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates.Candace L Haddox, Emanuele Mazzola, Jia-Ren Lin, Joanna Baginska, Allison Nau, Jason L Weirather, Adrian Marino-Enriquez, Jeffrey A Morgan, Priscilla Merriam, Andrew J...> ;Clinical Cancer Research. 2024 Apr 1
- Join now to see all
Journal Articles
- Translational Insights into Gastrointestinal Stromal Tumor and Current Clinical AdvancesM C Heinrich, S George, M L Hemming, Annals of Oncology
Lectures
- Mutation profile of drug resistant gastrointestinal stromal tumor (GIST) patients (pts) enrolled in the phase 1 study of DCC-2618.2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Other
- Surgical treatment and other localized therapy for metastatic soft tissue sarcomaGeorge S, Raut CP, Demetri GD
http://www.uptodate.com/contents/surgical-treatment-and-other-localized-therapy-for-metastatic-soft-
UpToDate, Wolters Kluwer Health - 2012-07-03 - Systemic treatment of metastatic soft tissue sarcomaGeorge S, Demetri GD
http://www.uptodate.com/contents/systemic-treatment-of-metastatic-soft-tissue-sarcoma
UpToDate, Wolters Kluwer Health - 2013-03-18
Press Mentions
Chemo-ICI Combo Promising in Soft Tissue SarcomaNovember 14th, 2021- The Life Raft Group, a Non-Profit Supporting Patients with GIST Cancer, Announces Members of the 2021 Medical Advisory BoardMarch 16th, 2021
Blueprint Medicines Wins FDA Approval for Its First DrugJanuary 9th, 2020- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
Brigham and Women's HospitalBoston, Massachusetts
Dana-Farber Cancer InstituteBoston, Massachusetts
Salem HospitalSalem, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
